These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26722077)

  • 1. Loss of Peroxiredoxin Expression Is Associated with an Aggressive Phenotype in Pancreatic Adenocarcinoma.
    Isohookana J; Haapasaari KM; Soini Y; Karihtala P
    Anticancer Res; 2016 Jan; 36(1):427-33. PubMed ID: 26722077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index.
    Kuusisto ME; Haapasaari KM; Turpeenniemi-Hujanen T; Jantunen E; Soini Y; Peroja P; Bloigu R; Karihtala P; Kuittinen O
    J Clin Pathol; 2015 Jul; 68(7):552-6. PubMed ID: 25935550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxiredoxins in breast carcinoma.
    Karihtala P; Mäntyniemi A; Kang SW; Kinnula VL; Soini Y
    Clin Cancer Res; 2003 Aug; 9(9):3418-24. PubMed ID: 12960131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas.
    Bur H; Haapasaari KM; Turpeenniemi-Hujanen T; Kuittinen O; Auvinen P; Marin K; Koivunen P; Sormunen R; Soini Y; Karihtala P
    Histopathology; 2014 Sep; 65(3):319-27. PubMed ID: 24698430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma.
    Kinnula VL; Lehtonen S; Sormunen R; Kaarteenaho-Wiik R; Kang SW; Rhee SG; Soini Y
    J Pathol; 2002 Mar; 196(3):316-23. PubMed ID: 11857495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and clinical value of peroxiredoxin-1 in patients with pancreatic cancer.
    Cai CY; Zhai LL; Wu Y; Tang ZG
    Eur J Surg Oncol; 2015 Feb; 41(2):228-35. PubMed ID: 25434328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma.
    Peroja P; Haapasaari KM; Mannisto S; Miinalainen I; Koivunen P; Leppä S; Karjalainen-Lindsberg ML; Kuusisto ME; Turpeenniemi-Hujanen T; Kuittinen O; Karihtala P
    Virchows Arch; 2016 May; 468(5):623-30. PubMed ID: 26983700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxiredoxins and their expression in ependymomas.
    Haapasalo T; Nordfors K; Järvelä S; Kok E; Sallinen P; Kinnula VL; Haapasalo HK; Soini Y
    J Clin Pathol; 2013 Jan; 66(1):12-7. PubMed ID: 23076395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung.
    Park JH; Kim YS; Lee HL; Shim JY; Lee KS; Oh YJ; Shin SS; Choi YH; Park KJ; Park RW; Hwang SC
    Respirology; 2006 May; 11(3):269-75. PubMed ID: 16635084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of redox-state-regulating enzymes in melanocytic skin tumours and the surrounding microenvironment.
    Hintsala HR; Soini Y; Haapasaari KM; Karihtala P
    Histopathology; 2015 Sep; 67(3):348-57. PubMed ID: 25627040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis.
    Pylväs M; Puistola U; Kauppila S; Soini Y; Karihtala P
    Eur J Cancer; 2010 Jun; 46(9):1661-7. PubMed ID: 20206498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of 8-hydroxydeoxyguanosine and peroxiredoxin II in the pathogenesis of endometriosis-associated ovarian cancer.
    Sova H; Kangas J; Puistola U; Santala M; Liakka A; Karihtala P
    Anticancer Res; 2012 Aug; 32(8):3037-44. PubMed ID: 22843871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxiredoxin III protects pancreatic ß cells from apoptosis.
    Wolf G; Aumann N; Michalska M; Bast A; Sonnemann J; Beck JF; Lendeckel U; Newsholme P; Walther R
    J Endocrinol; 2010 Nov; 207(2):163-75. PubMed ID: 20807727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor E2-related factor 2 dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer.
    Kim YS; Lee HL; Lee KB; Park JH; Chung WY; Lee KS; Sheen SS; Park KJ; Hwang SC
    Korean J Intern Med; 2011 Sep; 26(3):304-13. PubMed ID: 22016591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of neural cell types expressing peroxiredoxins in mouse brain.
    Jin MH; Lee YH; Kim JM; Sun HN; Moon EY; Shong MH; Kim SU; Lee SH; Lee TH; Yu DY; Lee DS
    Neurosci Lett; 2005 Jun; 381(3):252-7. PubMed ID: 15896479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of peroxiredoxin decreasing oxidative stress in hypertensive aortic smooth muscle.
    Lee CK; Kim HJ; Lee YR; So HH; Park HJ; Won KJ; Park T; Lee KY; Lee HM; Kim B
    Biochim Biophys Acta; 2007 Jul; 1774(7):848-55. PubMed ID: 17556052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.
    Soini Y; Haapasaari KM; Vaarala MH; Turpeenniemi-Hujanen T; Kärjä V; Karihtala P
    Int J Clin Exp Pathol; 2011 Mar; 4(3):267-75. PubMed ID: 21487522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancer.
    Woolston CM; Storr SJ; Ellis IO; Morgan DA; Martin SG
    Radiother Oncol; 2011 Aug; 100(2):308-13. PubMed ID: 21641069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative/nitrosative stress and peroxiredoxin 2 are associated with grade and prognosis of human renal carcinoma.
    Soini Y; Kallio JP; Hirvikoski P; Helin H; Kellokumpu-Lehtinen P; Kang SW; Tammela TL; Peltoniemi M; Martikainen PM; Kinnula VL
    APMIS; 2006 May; 114(5):329-37. PubMed ID: 16725008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors.
    Järvelä S; Rantala I; Rodriguez A; Kallio H; Parkkila S; Kinnula VL; Soini Y; Haapasalo H
    BMC Cancer; 2010 Mar; 10():104. PubMed ID: 20307276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.